Peripheral neuropathy — all decisions

The appeal was dismissed due to the Veteran's death while it was pending.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The Board remands the claims for service connection for diabetes mellitus and related conditions due to insufficient evidence of in-service herbicide exposure.

The appeal for service connection for multiple conditions was dismissed due to the untimely filing of the Board Appeal request.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The Board remands the claims for further development and readjudication.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The Board remands the claims for service connection for diabetes mellitus, type II (DMII), hypertension, peripheral vascular disease, bilateral diabetic retinopathy, and bilateral upper and lower diabetic peripheral neuropathy due to insufficient evidence regarding toxic exposures during military service.

The Board granted service connection for bilateral hearing loss and dismissed the appeal for an earlier effective date for tinnitus prior to February 2, 2024. The claims for a rating greater than 10 percent for tinea pedis, and for service connection for lumbar spine and bilateral lower extremity nerve conditions were remanded.

The Board remands the claims for service connection for various disabilities, including a neck disability, shoulder disabilities, hand disabilities, lower back disability, knee disabilities, psychiatric disorder, sinus headache, carpal tunnel syndrome, peripheral neuropathy, hypertension, and tinnitus, to ensure that VA has satisfied its duty to assist with regard to verifying all periods of service and obtaining medical records associated with the Veteran's service.

The Board remands the claims for additional development, including obtaining VA medical opinion and correcting duty to assist errors.

The Board granted a rating of 20 percent for both the left and right lower extremity neuropathy, as they are each productive of moderate incomplete paralysis of the sciatic nerve.

The Board remands the claims for service connection for diabetes mellitus type II and bilateral lower extremity (BLE) neuropathy to obtain additional private treatment records.

The Board of Veterans' Appeals remands the claims for further action as required by a Joint Motion for Remand.

The Board granted an effective date of May 24, 2021, for service connection for right and left upper extremity neuropathy and a 30 percent rating for the right upper extremity, while denying a higher rating for the left upper extremity.

The Board granted increased disability ratings of 70 percent for right upper extremity peripheral neuropathy, 60 percent for left upper extremity peripheral neuropathy, and 40 percent each for right and left lower extremity peripheral neuropathy, all effective from January 12, 2019.

The Board granted entitlement to special monthly compensation (SMC) at the (l) level based on loss of use of bilateral lower extremities due to service-connected bilateral lower extremity peripheral neuropathy.

The Board remands the claims for further development as there has not been substantial compliance with previous remand instructions.

The Board granted an effective date of August 9, 2023 for the award of service connection and increased ratings for several conditions, but remanded claims for higher initial disability ratings.